Medicolaser
ActiveThe computed 12-month bankruptcy probability of Medicolaser is 3.4% (moderate). The 2025 annual accounts show equity of €105k and a net result of €85k. Equity is growing by ~11.3% per year across the filed fiscal years. Its solvency ranks better than 37% of 4610 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
51
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability80▲+2
Solvency36▼-4
Growth78=
Track record94
Bankruptcy probability, 12 months
3.4%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days acceptable
Liquidity short (current ratio 0.33 against 0.49 in 2024; short-term debt: 25.5% and cash: 4.7% of total assets), and 88.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
11.1%
Return on assets
9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-04-2026, 95 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
95 d early
2024
27 d late
2023
30 d late
2022
22 d late
2021
5 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€105k▼ 32.8%
2024 · €156k
2021: €59k
2022: €104k
2023: €81k
2024: €156k
2021 → 2025
Total assets
€944k▼ 6.5%
2024 · €1.01M
2021: €511k
2022: €722k
2023: €1.13M
2024: €1.01M
2021 → 2025
Net result
€85k▲ 13.0%
2024 · €75k
2021: €-1k
2022: €46k
2023: €-24k
2024: €75k
2021 → 2025
Working capital
€-160k▼ 40.4%
2024 · €-114k
2021: €-132k
2022: €-112k
2023: €-526k
2024: €-114k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€59k-€104k▲ 77.7%€81k▼ 22.9%€156k▲ 93.4%€105k▼ 32.8%
Operating result€-1k-€76k€-15k€98k€122k▲ 25.2%
Net result€-1k-€46k€-24k€75k€85k▲ 13.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 25% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €944k
Fixed assets
€863k▼ 4.1%
Current assets
€80k▼ 26.9%
Equity and liabilities €944k
Equity
€105k▼ 32.8%
Debt
€839k▼ 1.8%
The debt ratio rises from 84.6% to 88.9%. Equity and debt are lower.
Key figures and ratios
EBITDA
€176k▼
2024 · €192k
Cash flow
€139k▼
2024 · €170k
Solvency
11.1%▼
2024 · 15.4%
Current ratio
0.33▼
2024 · 0.49
Quick ratio
0.33▼
2024 · 0.49
Debt / equity
8.02▲
2024 · 5.49
ROE
81.2%▲
2024 · 48.3%
ROA
9.0%▲
2024 · 7.4%
Interest coverage
20.70▲
2024 · 18.30
Debt
€839k▼
2024 · €854k
Debt ≤ 1 year
€240k▲
2024 · €224k
Debt > 1 year
€599k▼
2024 · €630k
Income taxes
€29k▲
2024 · €12k
Staff costs
€8k▲
2024 · €8k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.01M€944k▼
Fixed assets21/28€900k€863k▼
Intangible fixed assets21€9k€6k▼
Tangible fixed assets22/27€747k€714k▼
Land and buildings22€696k€669k▼
Plant, machinery and equipment23-€11k
Furniture and vehicles24€45k€28k▼
Other tangible fixed assets26€6k€6k▼
Financial fixed assets28€144k€144k=
Current assets29/58€110k€80k▼
Amounts receivable within one year40/41€50k€36k▼
Trade receivables40€14k€5k▼
Other amounts receivable41€35k€32k▼
Cash at bank and in hand54/58€60k€44k▼
Deferred charges and accrued income490/1€297€305▲
Equity and liabilities
Total equity and liabilities10/49€1.01M€944k▼
Equity10/15€156k€105k▼
Contributions10/11€60k€60k=
Reserves13€44k€44k=
Distributable reserves133€44k€44k=
Profit (loss) carried forward14€51k€199▼
Amounts payable17/49€854k€839k▼
Amounts payable after more than one year17€630k€599k▼
Financial debts170/4€630k€599k▼
Amounts payable within one year42/48€224k€240k▲
Current portion of amounts payable after more than one year42€32k€31k▼
Trade debts44€19k€6k▼
Suppliers440/4€19k€6k▼
Taxes, remuneration and social security45€9k€783▼
Taxes450/3€8k€591▼
Remuneration and social security454/9€933€192▼
Other amounts payable47/48€165k€202k▲
Income statement
Code20242025
Remuneration, social security and pensions62€8k€8k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€95k€54k▼
Other operating charges640/8€6k€6k▲
Gross operating margin9900€206k€191k▼
Operating profit (loss)9901€98k€122k▲
Financial income75/76B€10€7▼
Recurring financial income75€10€7▼
Financial charges65/66B€11k€9k▼
Recurring financial charges65€11k€9k▼
Profit (loss) for the period before taxes9903€87k€114k▲
Income taxes67/77€12k€29k▲
Profit (loss) for the period9904€75k€85k▲
Profit (loss) for the period to be appropriated9905€75k€85k▲
Appropriation of the result
Profit (loss) to be appropriated9906€51k€136k▲
Profit (loss) brought forward from the previous period14P€-24k€51k▲
Profit to be distributed694/7-€136k
Return on contributions (dividend)694-€136k
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2021net €85k ▲13%
Operating result €122k, net result €85k, both a record.
27-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 27 days late
2024
31-12
Financial
Back to profitnet €75k
Net result €75k after one loss-making year.
31-12
Financial
Equity above €150kEq €156k ▲93.4%
Equity rises from €81k to €156k.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-12
Financial
Weakest financial yearnet €-24k ▼152%
Net result drops to €-24k, the lowest in the series; recovery starts the following year.
22-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 22 days late
2022
31-12
Financial
Back to profitnet €46k
Net result €46k after one loss-making year.
31-12
Financial
Equity above €100kEq €104k ▲77.7%
Equity rises from €59k to €104k.
05-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 5 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Lambrechts-Woluwe · 3 establishment units since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
J.G. Van Goolenlaan 321200 Sint-Lambrechts-WoluweGround area
1,060 m²
Building footprint
608 m²
Volume, LiDAR
6,806 m³
2 parcels, Brussels · tallest building 17.5 m, ±5 floors. Linked by address, not a title deed.
3 establishment units
softtouch laser care
since 20212.316.273.193
softtouch-lasercare
since 20212.316.273.292
Medicolaser
since 20222.328.979.205
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21674C0312/00X006 | Brussels | 971 m² | 1 · 537 m² | 17.5 m · 5 fl. |
| 21447B0232/00B008 | Brussels | 89 m² | 1 · 72 m² | 11.9 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Afrodite Beauty
BE 0759.609.869
Torhout · Eq €105k
SUNPOWER
BE 0423.109.743
Kortrijk · Eq €104k
LOVINA SPA
BE 0502.554.327
Brussel · Eq €104k
BEAU VIE
BE 0664.736.545
Heusden-Zolder · Eq €104k
LG Zorg
BE 0794.935.487
Zoersel · Eq €104k
Of 24,863 companies in sector 96220 we hold annual accounts for 1,443. 1,002 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded02-04-2021
Fiscal year end31-12
Activities, NACEBEL
96022Beauty treatment
96220Beauty care and other beauty treatments
47750Retail sale of cosmetics and toilet articles
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
4 entriesWebsite:www.softtouch-lasercare.be
E-mail:info@stlc.be
Phone:0472818100
Website:www.softouch-lasercare.be